Présentation PowerPoint
Assessing Use of the EQ-VAS in the NHS PROMs Programme - OHE
![PDF] Reliability and validity of the Thai version of EQ-5 D-5 L questionnaire on patients with chronic disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/de8012596c2577dd89a4200991e02054125bab6d/10-Table5-1.png "PDF] Reliability and validity of the Thai version of EQ-5 D-5 L questionnaire on patients with chronic disease | Semantic Scholar")
PDF] Reliability and validity of the Thai version of EQ-5 D-5 L questionnaire on patients with chronic disease | Semantic Scholar
EuroQol Whiteboard Animation THE EQ VISUAL ANALOGUE SCALE EQ VAS - YouTube
Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden | Health and Quality of Life Outcomes | Full Text
README
xmlinkhub
![Visual analog scale (VAS) used by the Euroqol Group. Source: Ref. [48] | Download Scientific Diagram](https://www.researchgate.net/publication/26874451/figure/fig1/AS:601768081776671@1520484099632/Visual-analog-scale-VAS-used-by-the-Euroqol-Group-Source-Ref-48.png "Visual analog scale (VAS) used by the Euroqol Group. Source: Ref. [48] | Download Scientific Diagram")
Visual analog scale (VAS) used by the Euroqol Group. Source: Ref. [48] | Download Scientific Diagram
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to. - ppt download
Meaningful values of the EQ-5D-3L in patients undergoing primary knee arthroplasty | Bone & Joint
Comparison of EQ-5D-5L Utility Values and VAS Scores to Norms | Download Scientific Diagram
Appendix I. Sample Descriptives: EQ5D and EQ-VAS | Food Standards Agency
Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders | European Psychiatry | Cambridge Core
Comparative responsiveness of the PROMIS-10 Global Health and EQ-5D questionnaires in patients undergoing total knee arthroplasty | Bone & Joint
Visual analog scale (VAS) and time trade-off (TTO) Models for EQ-5D. | Download Table
Predicting EQ-5D-5L Utility Scores from the Oswestry Disability Index | JPR
Full article: A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values
Part 2 of the EQ 5D 3L survey: visual analogue scale (VAS). | Download Scientific Diagram
Five dimensions of EQ-5D and visual analogue scale (VAS) score. | Download Scientific Diagram
Appendix I. Sample Descriptives: EQ5D and EQ-VAS | Food Standards Agency
![Fig. 1.4, [EQ VAS (current EQ-5D-5L and EQ-5D-3L version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK565680/bin/456601_1_En_1_Fig4_HTML.jpg "Fig. 1.4, [EQ VAS (current EQ-5D-5L and EQ-5D-3L version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf")
Fig. 1.4, [EQ VAS (current EQ-5D-5L and EQ-5D-3L version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf
Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry - MDS Abstracts
EQ-5D-3L Part 2: visual analogue scale (VAS). | Download Scientific Diagram
![Fig. 1.6, [EQ VAS (EQ-5D-Y version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK565680/bin/456601_1_En_1_Fig6_HTML.jpg "Fig. 1.6, [EQ VAS (EQ-5D-Y version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf")
Fig. 1.6, [EQ VAS (EQ-5D-Y version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf
EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading
A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the Oxford Hip Score in the Australian hip arthroplasty population | Journal of Patient-Reported Outcomes | Full Text
